Roswell Park Announces Positive Progress in Clinical Trial of Novel Immunotherapy SurVaxM
Highlights Promising immunotherapy was developed at Roswell Park Study assesses possible survival benefit for newly diagnosed patients receivin Studies underway in glioblastoma, multiple myeloma and pediatric brain tumors Newswise — BUFFALO, N.Y. — Roswell …